e-learning
resources
Vienna 2009
Monday, 14.09.2009
Clinical immunology of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Interrelation between
mTB
multi drug-resistance and cytokine activity in pulmonary TB patients and
mTB
virulence
L. Surkova, N. Shpakovskaya, A. Zalutskaya, A. Skrahina, Z. Rohava (Minsk, Belarus)
Source:
Annual Congress 2009 - Clinical immunology of tuberculosis
Session:
Clinical immunology of tuberculosis
Session type:
Thematic Poster Session
Number:
2577
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Surkova, N. Shpakovskaya, A. Zalutskaya, A. Skrahina, Z. Rohava (Minsk, Belarus). Interrelation between
mTB
multi drug-resistance and cytokine activity in pulmonary TB patients and
mTB
virulence. Eur Respir J 2009; 34: Suppl. 53, 2577
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Role of cytokines in the immunopathogenesis of the MDR pulmonary tuberculosis
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
The emerging problem of treating pulmonary
M. avium complex
(MAC) disease – microbial substitution of MAC to
M. abscessus
,
Scedosporium
and
Nocardia
after multi-drug chemotherapy in pulmonary MAC disease
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Antituberculous activity of fiurenizid in vitro and in patients with destructive pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 724s
Year: 2004
Role of cytokines in regulation of inflammatory and protective reactions in progression of pulmonary MDR tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Surgical treatment of destructive pulmonary tuberculosis (TB) with multi-drug resistance (MDR)
Source: Eur Respir J 2004; 24: Suppl. 48, 723s
Year: 2004
Characteristics of the cases with primary multidrug resistance pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 652s
Year: 2005
Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
Drug resistance patterns in patients with multi-drug resistant tuberculosis (MDR – TB)
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Prevalence of pulmonary tuberculosis in spinal tuberculosis patients
Source: International Congress 2017 – TB: diagnosis, severity and practical management
Year: 2017
Cytokine gene polymorphisms and
mycobacterium tuberculosis
: from infection to pulmonary disease
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006
Primary drug resistance in pulmonary tuberculosis
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
The significance of the antigen-specific IFN-γ release assay
in vitro
for differential diagnosis between sarcoidosis and tuberculosis (TB) patients
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010
Peculiarities and results of treatment in XDR pulmonary tuberculosis (PTB)
Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences
Year: 2012
Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
IFN-γ response on T-cell based assays for the diagnosis of tuberculosis infection in rheumatic patients undergoing anti-TNF-α treatment
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Structure of drug resistance of M. tuberculosis in children and adolescents with pulmonary TB
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002
Outcome of zinc & vit-A supplementation in the treatment
multidrug resistance
pulmonary tuberculosis patients
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept